Nutex Health [NUTX] vs Pediatrix Medical [MD] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Nutex Health Inc. wins in 11 metrics, Pediatrix Medical Group, Inc. wins in 9 metrics, with 0 ties. Nutex Health Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Nutex Health Inc. Pediatrix Medical Group, Inc. Better
P/E Ratio (TTM) 10.34 11.88 Nutex Health Inc.
Price-to-Book Ratio 2.33 2.16 Pediatrix Medical Group, Inc.
Debt-to-Equity Ratio 82.99 73.29 Pediatrix Medical Group, Inc.
PEG Ratio 5.33 9.90 Nutex Health Inc.
EV/EBITDA 2.46 7.92 Nutex Health Inc.
Profit Margin (TTM) 8.09% 8.64% Pediatrix Medical Group, Inc.
Operating Margin (TTM) 97.52% 11.07% Nutex Health Inc.
EBITDA Margin (TTM) 97.52% 11.07% Nutex Health Inc.
Return on Equity 58.94% 20.28% Nutex Health Inc.
Return on Assets (TTM) 31.18% 6.57% Nutex Health Inc.
Free Cash Flow (TTM) $245.60M $252.63M Pediatrix Medical Group, Inc.
1-Year Return -23.03% 52.23% Pediatrix Medical Group, Inc.
Price-to-Sales Ratio (TTM) 0.88 1.00 Nutex Health Inc.
Enterprise Value $1.02B $2.00B Pediatrix Medical Group, Inc.
EV/Revenue Ratio 1.16 1.05 Pediatrix Medical Group, Inc.
Gross Profit Margin (TTM) 30.42% 25.51% Nutex Health Inc.
Revenue per Share (TTM) $138 $23 Nutex Health Inc.
Earnings per Share (Diluted) $10.48 $1.94 Nutex Health Inc.
Beta (Stock Volatility) 2.03 0.72 Pediatrix Medical Group, Inc.
Short % of Float 22.39% 6.00% Pediatrix Medical Group, Inc.

Nutex Health Inc. vs Pediatrix Medical Group, Inc. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Nutex Health Inc.6.24%11.20%-9.74%18.70%0.82%-10.37%
Pediatrix Medical Group, Inc.0.37%0.88%-2.54%10.64%-6.23%2.58%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Nutex Health Inc.-23.03%90.34%-90.45%-90.45%-90.45%-90.45%
Pediatrix Medical Group, Inc.52.23%53.97%-32.60%-68.09%-39.53%-4.27%

Performance & Financial Health Analysis: Nutex Health Inc. vs Pediatrix Medical Group, Inc.

MetricNUTXMD
Market Information
Market Cap i$772.96M$1.91B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i194,554510,889
90 Day Avg. Volume i186,735755,756
Last Close$132.83$21.84
52 Week Range$77.21 - $193.07$11.84 - $24.99
% from 52W High-31.20%-12.61%
All-Time High$5,250.00 (Apr 04, 2022)$86.09 (Aug 17, 2015)
% from All-Time High-97.47%-74.63%
Growth Metrics
Quarterly Revenue Growth-0.41%-0.02%
Quarterly Earnings Growth-0.81%0.11%
Financial Health
Profit Margin (TTM) i0.08%0.09%
Operating Margin (TTM) i0.98%0.11%
Return on Equity (TTM) i0.59%0.20%
Debt to Equity (MRQ) i82.9973.29
Cash & Liquidity
Book Value per Share (MRQ)$46.49$10.68
Cash per Share (MRQ)$26.63$6.16
Operating Cash Flow (TTM) i$248.12M$271.09M
Levered Free Cash Flow (TTM) i$152.81M$190.33M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Nutex Health Inc. vs Pediatrix Medical Group, Inc.

MetricNUTX (Apr 24, 2026)MD (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i10.3411.88
Forward P/E i5.339.90
PEG Ratio i5.339.90
Price to Sales (TTM) i0.881.00
Price to Book (MRQ) i2.332.16
Market Capitalization
Market Capitalization i$772.96M$1.91B
Enterprise Value i$1.02B$2.00B
Enterprise Value Metrics
Enterprise to Revenue i1.161.05
Enterprise to EBITDA i2.467.92
Risk & Other Metrics
Beta i2.030.72
Book Value per Share (MRQ) i$46.49$10.68

Financial Statements Comparison: Nutex Health Inc. vs Pediatrix Medical Group, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNUTX (2025)MD (2025)
Revenue/Sales i875.26M1.91B
Cost of Goods Sold i430.98M1.42B
COGS % of Revenue i49.2%74.2%
Gross Profit i444.28M493.70M
Gross Margin i50.8%25.8%
Research & Development iN/AN/A
Operating Income (EBIT) i275.63M231.09M
Operating Margin i31.5%12.1%
EBITDA i287.54M256.55M
EBITDA Margin i32.9%13.4%
Pre-Tax Income i244.78M216.43M
Pre-Tax Income % of Revenue i28.0%11.3%
Income Tax i64.42M51.04M
Income Tax % of Revenue i7.4%2.7%
Net Income (Profit) i180.36M165.39M
Profit Margin i20.6%8.6%

Balance Sheet & Liquidity Metrics

MetricNUTX (2025)MD (2025)
Cash & Equivalents i185.57M375.24M
Total Current Assets i538.81M763.51M
Total Current Assets % of Revenue i61.6%39.9%
Total Current Liabilities i157.91M458.91M
Total Current Liabilities % of Revenue i18.0%24.0%
Long-Term Debt i328.09M596.22M
Long-Term Debt % of Revenue i37.5%31.2%
Total Shareholders Equity i423.44M865.85M
Retained Earnings i-286.19M-83.15M
Retained Earnings % of Revenue i-32.7%-4.3%
Property, Plant & Equipment i287.01M195.53M

Cash Flow Statement Comparison

MetricNUTX (2025)MD (2025)
Operating Cash Flow i284.80M270.23M
Operating Cash Flow % of Revenue i32.5%14.1%
Capital Expenditures i-2.53M-18.46M
Free Cash Flow i245.60M252.63M
FCF Margin i28.1%13.2%
Debt Repayment i-24.48M-20.75M
Common Stock Repurchase i-5.00M-86.68M

Short Interest & Institutional Ownership Analysis

MetricNUTXMD
Shares Short i994,3413.53M
Short Ratio i4.523.77
Short % of Float i22.39%6.00%
Shares Outstanding i7.09M82.98M
Float Shares i3.94M79.95M
% Held by Insiders i28.66%2.31%
% Held by Institutions i40.16%106.63%
% Held by Public i31.18%-8.94%

Dividend Analysis & Yield Comparison: Nutex Health Inc. vs Pediatrix Medical Group, Inc.

MetricNUTXMD
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A